Monograph: THERMODYNAMIC CORRIDOR OF BIOSYSTEM ADAPTIVE RESILIENCE: A System-Oriented Model of Energy, Information and Structural Optimisation for the Prevention of Biological Ageing
Volodymyr Naumenko
Founder & CEO, Patented MT Company (Vilnius, Lithuania)
Academician of the Ukrainian Technological Academy
Department of Modern Medical Technologies and Ecology
ORCID: 0009-0000-3965-5205
A Manifesto for the Prevention of Biological Ageing. This fundamental monograph represents the definitive synthesis of 13 years of systematic research, engineering design, and scientific innovation by Inventor Volodymyr Naumenko. The work provides a critical alternative to the modern deadlock of symptomatic medicine, introducing a comprehensive biocybernetic approach to actively slowing down and preventing the processes of biological ageing.
A Technological Blueprint for Advanced Longevity Clinics. This book is specifically tailored for progressive medical centers, longevity institutes, and anti-ageing clinics catering to high-value clients who demand scientifically validated, proactive solutions for age prevention. It serves as an authoritative clinical and engineering reference, bridges the gap between systems biology and practical gerontological protocols, and offers a comprehensive framework to transition from standard symptom-management to managing the total thermodynamic and energetic sovereignty of the human organism.
The monograph details the theoretical foundation and practical application of the proprietary MSPM–NASP Framework (Immanent Therapy®). It reveals how the dual-loop synchronisation of a Molecularly Structured Protein Matrix (substrate loop) and a Neuroacoustic Stimulation Protocol (informational loop) expands the thermodynamic corridor of biosystem adaptive resilience. By eliminating the cellular enthalpic barrier of the gastrointestinal tract and enforcing the Zero-ATP Waste Principle, the framework allows linearized peptide matrix systems to be absorbed without expending the cell’s scarce ATP resources. Concurrently, the neuroacoustic protocol suppresses systemic and receptor noise, establishing microvascular decompression, restoring laminar blood flow at a resonance frequency of ~0.1 Hz, and arresting chronic tissue hypoxia, ischemia, and subsequent fibrosis—particularly within critical cardio-vascular and reproductive target organs (such as the prostate and uterus).
FULL MONOGRAPH TEXT available via DOI: https://doi.org/10.5281/zenodo.20687686